The newly identified Pard3/RhoA/NF‐κB pathway may help us to further illuminate the complicated molecular mechanisms of Par complexes and presents a novel strategy for diagnosing and therapy with glioma. This evidence concerns the gene RHOA and central nervous system cancer.